{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:07:25Z","timestamp":1777748845958,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 98937"],"award-info":[{"award-number":["UID 98937"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["115349"],"award-info":[{"award-number":["115349"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016979","name":"National Treasury","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016979","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bioorg.2020.103587","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:17:26Z","timestamp":1579173446000},"page":"103587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues"],"prefix":"10.1016","volume":"96","author":[{"given":"Nonkululeko H.","family":"Zuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnett","family":"Seldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Aucamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Jordaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digby F.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"N'Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103587_b0005","unstructured":"WHO, Global Tuberculosis Report 2018. Available at: apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?ua=1. Date accessed 31 October 2018."},{"key":"10.1016\/j.bioorg.2020.103587_b0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijid.2017.01.012","article-title":"Turning the tide against tuberculosis","volume":"56","author":"Padayatchi","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103587_b0015","unstructured":"WHO, Global Tuberculosis Report 2017. Available at: who.int\/iris\/bitstream\/10665\/259366\/1\/9789241565516-eng.pdf. Date accessed 25 March 2018."},{"key":"10.1016\/j.bioorg.2020.103587_b0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","article-title":"Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence","volume":"16","author":"Smith","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2020.103587_b0025","first-page":"10","article-title":"Tuberculosis 2: pathophysiology and microbiology of pulmonary tuberculosis","volume":"6","author":"Wani","year":"2013","journal-title":"South. Sudan. Med. J."},{"key":"10.1016\/j.bioorg.2020.103587_b0030","doi-asserted-by":"crossref","first-page":"e00021","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2020.103587_b0035","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.070","article-title":"The biology of mycobacterium tuberculosis infection","volume":"5","author":"Delogu","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103587_b0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1574-6976.2008.00107.x","article-title":"Reduction of polynitroaromatic compounds: the bacterial nitroreductases","volume":"32","author":"Roldan","year":"2008","journal-title":"FEMS. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2020.103587_b0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000401065","article-title":"The pharmacokinetics of nitrofurantoin and its related bioavailability","volume":"25","author":"Conklin","year":"1978","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0050","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/jf062902a","article-title":"Determinations of residual furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ), in fish feeds by HPLC-UV and LC-MS\/MS, respectively","volume":"55","author":"Hu","year":"2007","journal-title":"J. Agri. Food. Chem."},{"key":"10.1016\/j.bioorg.2020.103587_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.bioorg.2020.103587_b0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.freeradbiomed.2007.12.013","article-title":"Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity","volume":"44","author":"Wang","year":"2008","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2020.103587_b0065","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.01213-09","article-title":"Exploiting the Drug-Activating Properties of a Novel Trypanosomal Nitroreductase","volume":"54","author":"Hall","year":"2010","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/jac\/46.6.917","article-title":"Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG","volume":"46","author":"Murugasu-Oei","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chembiol.2012.05.017","article-title":"ALDH2 mediates 5-nitrofuran activity in multiple species","volume":"19","author":"Zhou","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2020.103587_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11094-005-0161-5","article-title":"Hydrolytic and reductive transformations of nifuroxazide","volume":"39","author":"Trukhacheva","year":"2005","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2020.103587_b0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/jm901378u","article-title":"Synthesis and structure\u2212 activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains","volume":"53","author":"Sutherland","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103587_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0005-2728(88)90261-7","article-title":"Mechanism of nitrofurantoin toxicity and oxidative stress in mitochondria","volume":"936","author":"Carbonera","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2020.103587_b0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0006-2952(79)90142-4","article-title":"Metabolic activation of nitrofurantoin-possible implications for carcinogenesis","volume":"28","author":"Boyd","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103587_b0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/AAC.01459-13","article-title":"Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs","volume":"58","author":"Voak","year":"2013","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/abbi.2001.2670","article-title":"Revisiting the interaction of the radical anion metabolite of nitrofurantoin with glutathione","volume":"397","author":"Miller","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2020.103587_b0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/mutage\/gel036","article-title":"Organ-targeted mutagenicity of nitrofurantoin in Big Blue transgenic mice","volume":"21","author":"Quillardet","year":"2006","journal-title":"Mutagenesis"},{"key":"10.1016\/j.bioorg.2020.103587_b0115","unstructured":"M.P. de A. Farias, A.C.L. Leite, D.R. de M. Moreira, et al., Evaluation of novel N2-alkyl and N2,N4-dialkyl Nitrofurazones derivatives as a possible antituberculosis agents, J Braz Chem Soc. (2006) 29."},{"key":"10.1016\/j.bioorg.2020.103587_b0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tiv.2012.01.018","article-title":"Caco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against Methicillin-resistant Staphylococcus aureus (MRSA)","volume":"26","author":"Fernandes","year":"2012","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bioorg.2020.103587_b0125","article-title":"An update on derivatisation and repurposing of clinical nitrofuran drugs","volume":"105092","author":"Zuma","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.103587_b0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.mi.49.100195.002515","article-title":"Biodegradation of nitroaromatic compounds","volume":"49","author":"Spain","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2020.103587_b0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3821\/1913-701X-142.5.248","article-title":"A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment","volume":"142","author":"Bains","year":"2009","journal-title":"Can. Pharm. J."},{"key":"10.1016\/j.bioorg.2020.103587_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200161030-00004","article-title":"An Update on the role of nitrofurans in the management of urinary tract infections","volume":"61","author":"Guay","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2020.103587_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antibiotics3010039","article-title":"Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of lower urinary tract infections","volume":"3","author":"Munoz-Davila","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2020.103587_b0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0006-2952(83)90527-0","article-title":"Increased biliary secretion and loss of hepatic glutathione in rat liver after nifurtimox treatment","volume":"32","author":"Dubin","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103587_b0155","first-page":"51S","article-title":"Nitrofurantoin: potential direct and indirect mechanisms of lung injury","volume":"83","author":"Martin","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.bioorg.2020.103587_b0160","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1016\/j.bmcl.2011.07.002","article-title":"Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors","volume":"21","author":"Cakmak","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103587_b0165","first-page":"29","article-title":"Stability of nitrofurantoin in extemporaneously compounded suspensions","volume":"59","author":"Ensom","year":"2006","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.bioorg.2020.103587_b0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4046\/trd.2017.0052","article-title":"Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy","volume":"81","author":"Kim","year":"2018","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.bioorg.2020.103587_b0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"LoBue","year":"2003","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"10.1016\/j.bioorg.2020.103587_b0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/ph5070690","article-title":"Chemotherapeutic interventions against tuberculosis","volume":"5","author":"Shakya","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2020.103587_b0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target","volume":"185","author":"Lin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2020.103587_b0190","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jac\/dkv417","article-title":"Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomes","volume":"71","author":"Bruhn","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/AAC.45.1.306-308.2001","article-title":"Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance","volume":"45","author":"Kwon","year":"2001","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ardp.200700243","article-title":"Novel nitrofurazone derivatives endowed with antimicrobial activity","volume":"341","author":"Brondani","year":"2008","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.103587_b0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1177391X0700100003","article-title":"The pKa distribution of drugs: application to drug discovery","volume":"1","author":"Manallack","year":"2007","journal-title":"Perspect. Medicin. Chem."},{"key":"10.1016\/j.bioorg.2020.103587_b0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Van De Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2020.103587_b0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/138920006775541552","article-title":"Preclinical pharmacokinetics: an approach towards safer and efficacious drugs","volume":"7","author":"Singh","year":"2006","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.bioorg.2020.103587_b0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.14573\/altex.2013.3.275","article-title":"Food for thought look back in anger\u2013What clinical studies tell us about preclinical work","volume":"30","author":"Hartung","year":"2013","journal-title":"Altex"},{"key":"10.1016\/j.bioorg.2020.103587_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.103587_b0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1359-6446(02)02556-4","article-title":"Chris Lipinski discusses life and chemistry after the Rule of Five","volume":"8","author":"Owens","year":"2003","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.bioorg.2020.103587_b0240","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1128\/jcm.30.7.1815-1822.1992","article-title":"Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis","volume":"30","author":"Plikaytis","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2020.103587_b0245","doi-asserted-by":"crossref","unstructured":"J. Oravcov\u00e1, B. Bo\u00a8hs, W. Lindner, Review: Drug-protein binding studies new trends in analytical and experimental methodology, J Chromatogr B Biomed Sci Appl. 677 (1996) 1\u201328.","DOI":"10.1016\/0378-4347(95)00425-4"},{"key":"10.1016\/j.bioorg.2020.103587_b0250","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bmc.2010.12.054","article-title":"Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides","volume":"19","author":"Zitko","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103587_b0255","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.bmcl.2011.12.129","article-title":"Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles","volume":"22","author":"Zitko","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103587_b0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0041-3879(77)90022-8","article-title":"The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide","volume":"59","author":"Girling","year":"1978","journal-title":"Tubercle"},{"key":"10.1016\/j.bioorg.2020.103587_b0265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2020.103587_b0270","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1039\/C5MD00057B","article-title":"1, 2, 3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study","volume":"6","author":"Shaikh","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2020.103587_b0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103587_b0280","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00044-019-02458-7","article-title":"Synthesis and antimycobacterial activity of disubstituted benzyltriazoles","volume":"28","author":"Smit","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.103587_b0285","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41598-018-23110-1","article-title":"Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)","volume":"8","author":"Baptista","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2020.103587_b0290","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1128\/AAC.01178-16","article-title":"Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery","volume":"60","author":"Naran","year":"2016","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.bioorg.2020.103587_b0295","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1021\/acs.jmedchem.7b01347","article-title":"Novel antitubercular 6-dialkylaminopyrimidine carboxamides from phenotypic whole-cell high throughput screening of a soft focus library: Structure-activity relationship and targetidentification studies","volume":"60","author":"Wilson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103587_b0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819316736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819316736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:50:17Z","timestamp":1777463417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819316736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":60,"alternative-id":["S0045206819316736"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103587","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103587"}}